Back to Search
Start Over
Effects of Transcutaneous Electrical Acupoint Stimulation on Patients with Stable Chronic Obstructive Pulmonary Disease: A Prospective, Single-Blind, Randomized, Placebo-Controlled Study.
- Source :
- Journal of Alternative & Complementary Medicine; Oct2015, Vol. 21 Issue 10, p610-616, 7p, 1 Diagram, 2 Charts, 1 Graph
- Publication Year :
- 2015
-
Abstract
- Objectives: To evaluate the clinical effect of transcutaneous electrical nerve stimulation over acupoints (acu-TENS) on patients with stable chronic obstructive pulmonary disease (COPD). Design: Prospective, single-blind, randomized, placebo-controlled study. Settings/Locations: Outpatient center of West China Hospital, Sichuan University. Patients: Fifty patients with stable COPD enrolled in the study. Interventions: Patients were randomly assigned to one of two groups: the acu-TENS group ( n=25), who underwent acu-TENS over acupoints of bilateral EX-B-1( Dingchuan), BL-13 ( Feishu), BL-23 ( Shenshu), ST-36 ( Zusanli), and the placebo acu-TENS control group ( n=25), who had the same electrode placement but no electrical output. Treatments were performed for 40-minute sessions every 2 days for 4 weeks. Outcome measures: Lung function (forced expiratory volume in 1 second, percentage predicted (FEV<subscript>1</subscript>% predicted); forced vital capacity, percentage predicted (FVC% predicted), 6-minute walk distance (6MWD) and oxygen saturation (SpO<subscript>2</subscript>), COPD assessment test (CAT), and Dyspnea Visual Analogue Scale (DVAS) were assessed before and after the intervention. Results: Compared to control group, FEV<subscript>1</subscript>% predicted was improved and CAT score was decreased significantly in the acu-TENS group after treatment ( p<0.05). The DVAS score decreased significantly in the acu-TENS group ( p=0.039), with a slight but insignificant improve in 6MWD, SpO<subscript>2</subscript>, and FVC% predicted after treatment. Conclusions: Acu-TENS over acupoints of bilateral EX-B-1 ( Dingchuan), BL-13 ( Feishu), BL-23 ( Shenshu), and ST-36 ( Zusanli) improved FEV<subscript>1</subscript>% predicted and reduced DVAS and CAT scores on patients with stable COPD. This may be a novel treatment strategy in COPD. [ABSTRACT FROM AUTHOR]
- Subjects :
- DIAGNOSIS of dyspnea
OBSTRUCTIVE lung disease treatment
WALKING
ACTIVE oxygen in the body
ACUPUNCTURE points
ALTERNATIVE medicine
LONGITUDINAL method
PROBABILITY theory
RESEARCH funding
RESPIRATORY measurements
PULMONARY function tests
STATISTICAL sampling
STATISTICAL hypothesis testing
T-test (Statistics)
TRANSCUTANEOUS electrical nerve stimulation
STATISTICAL power analysis
STATISTICAL significance
BODY mass index
RANDOMIZED controlled trials
VISUAL analog scale
TREATMENT effectiveness
PRE-tests & post-tests
VITAL capacity (Respiration)
BLIND experiment
DATA analysis software
DESCRIPTIVE statistics
Subjects
Details
- Language :
- English
- ISSN :
- 10755535
- Volume :
- 21
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Journal of Alternative & Complementary Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 110221560
- Full Text :
- https://doi.org/10.1089/acm.2014.0284